HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$42.93
Day range
$42.24 - $43.02
Year range
$27.99 - $50.99
Market cap
3.21B USD
Avg Volume
323.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 12.62M | 48.44% |
Net income | -44.74M | -19.65% |
Net profit margin | — | — |
Earnings per share | -0.64 | -12.28% |
EBITDA | -52.84M | -23.42% |
Effective tax rate | 0.46% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 638.08M | 7.77% |
Total assets | 964.80M | 27.93% |
Total liabilities | 36.88M | 12.95% |
Total equity | 927.92M | — |
Shares outstanding | 75.43M | — |
Price to book | 3.49 | — |
Return on assets | -16.41% | — |
Return on capital | -16.92% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -44.74M | -19.65% |
Cash from operations | -35.46M | -8.35% |
Cash from investing | -239.73M | -1,572.31% |
Cash from financing | 324.01M | 5,400,133.33% |
Net change in cash | 49.07M | 206.10% |
Free cash flow | -23.67M | -81.41% |
About
Founded
1996
Headquarters
Website
Employees
255